Atogepant
157 interactions 1 explained in plain English 45 cited referencesAtogepant is a calcitonin gene-related peptide receptor antagonist used to help prevent migraine headaches. Read the full Atogepant drug information page →
Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →
Major
Atogepant Oxcarbazepine Oxtellar Reduced atogepant exposure Details Atogepant Paritaprevir Increased atogepant exposure Details Atogepant Pexidartinib Turalio Reduced atogepant exposure Details Atogepant Phenobarbital Fidoquel Reduced atogepant exposure Details Atogepant Phenytoin Dilantin Reduced atogepant exposure Details Atogepant Pibrentasvir Increased atogepant exposure Details Atogepant Pioglitazone Actos Reduced atogepant exposure Details Atogepant Pitolisant Wakix Reduced atogepant exposure Details Atogepant Posaconazole Noxafil Increased atogepant exposure Details Atogepant Prednisone Deltasone Reduced atogepant exposure Details Atogepant Pretomanid Reduced atogepant exposure Details Atogepant Primidone Mysoline Reduced atogepant exposure Details Atogepant Quercetin Reduced atogepant exposure Details Atogepant Raltegravir Isentress Reduced atogepant exposure Details Atogepant Ranolazine Aspruzyo Increased exposure of CYP3A4 substrate Details Atogepant Relacorilant Lifyorli Increased CYP3A4 substrate exposure and an increased risk of CYP3A4-substrate-related adverse reactions Details Atogepant Repotrectinib Augtyro Reduced atogepant exposure Details Atogepant Resmetirom Rezdiffra Increased atogepant exposure Details Atogepant Ribociclib Kisqali Increased atogepant exposure Details Atogepant Rifabutin Mycobutin Reduced atogepant exposure Details Atogepant Rifampin Rifadin Altered atogepant exposure Details Atogepant Rifapentine Priftin Reduced atogepant exposure Details Atogepant Ritonavir Norvir Altered atogepant exposure Details Atogepant Rufinamide Banzel Reduced atogepant exposure Details Atogepant Sacubitril Increased atogepant exposure Details Atogepant Safinamide Xadago Reduced atogepant exposure Details Atogepant Saquinavir Increased atogepant exposure Details Atogepant Sarilumab Reduced atogepant exposure Details Atogepant Semaglutide Ozempic Increased atogepant exposure Details Atogepant Sildenafil Liqrev Increased atogepant exposure Details Atogepant Simeprevir Olysio® Increased atogepant exposure Details Atogepant Sotagliflozin Inpefa Reduced atogepant exposure Details Atogepant Sotorasib Lumakras Reduced atogepant exposure Details Atogepant St John's Wort Reduced atogepant exposure Details Atogepant Sulfinpyrazone Reduced atogepant exposure Details Atogepant Suzetrigine Journavx Reduced sensitive CYP3A substrate exposure and reduced efficacy of sensitive CYP3A substrate Details Atogepant Tazemetostat Tazverik Reduced atogepant exposure Details Atogepant Tecovirimat Reduced atogepant exposure Details Atogepant Telaprevir Altered atogepant exposure Details Atogepant Telithromycin Increased atogepant exposure DetailsNo interactions on this page match that filter — try the next page or clear the filter.
Check another drug
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist